Post by Axplora

🚴 Today, the Tour de France arrives in Pau, just a few kilometers from our Mourenx site. 👕🟡 Every stage has its winner. But no rider gets there alone. The same is true when transforming a site alongside a trusted partner. Behind the €60 million investment in Mourenx are over 100 colleagues from four Axplora sites, working side by side with our customers to build far more than a facility. They built new skills, developed new expertise, and shared one ambition. Together, they embraced one of our industry's most exciting challenges: building the capabilities needed for the next generation of GLP-1 therapies tackling diabetes and obesity by transforming Mourenx into Axplora's center of excellence for API and drug substance manufacturing for FDA-approved biologics. It wasn't always easy—but one mindset kept the project moving forward: "𝗟𝗲𝘁'𝘀 𝗴𝗼 𝗳𝗼𝗿 𝗶𝘁!" 🏔️ Just like in cycling, the toughest mountains are never conquered alone. This project proves it once again—for the benefit of patients. #Axplora #GLP1 #Manufacturing #Teamwork #TourdeFrance

Video Content